J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Mr. Finney brings 35 years of leadership, operations and corporate development experience SOUTH SAN FRANCISCO, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or ...

FTSE rebounds to edge higher amid strong consumer stocks - The FTSE 100 finished 1.36 points higher to end the day at ...

Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and ...

At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.

“We are pleased to welcome Reena to Applied and are confident that her wealth of experience as a leader across quality functions will support our mission of meeting the unmet needs of patients with ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

But as folks contend with their New Year’s resolutions—especially those in the “This is the year I’ll work out more” category—they might also consider a new element to their health ...

who was previously CEO of British drugmaker GlaxoSmithKline. UnitedHealth, which operates the biggest health insurer in the United States, a large pharmacy benefit manager, and other businesses ...

CHATTANOOGA, Tenn., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Bridges Consumer Healthcare LLC (“Bridges” or the “Company”), a consumer healthcare platform made up of nine over-the-counter (“OTC ...